AGRX News and Press, Agile Therapeutics Inc. From 10/28/19

Gainers:  Tiffany & Co. (NYSE: TIF ) +31% . Xunlei Limited (NASDAQ: XNET ) +27% . Datasea (NASDAQ: DTSS ) +25% . comScore (NASDAQ: SCOR ) +24% . Fitbit (NYSE: FIT ) +23% . Aquestive Therapeutics (NASDAQ: AQST ) +23% . ChinaNet Online Holdings (NASDAQ: CNET ) +20% . Libbey (...

Nano cap Agile Therapeutics ( AGRX -52.2% ) slumps on more than a 13x surge in volume in reaction to the FDA's briefing document ahead of Wednesday's meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee to review and discuss its (third) marketing application for contrace...

PG&E (NYSE: PCG ) -28%  as more mass power shutdowns loom . More news on: PG&E Corporation, Agile Therapeutics, Inc., NIO Inc., Stocks on the move, Read more ...

Agile Therapeutics (NASDAQ: AGRX ): Q3 GAAP EPS of -$0.08 in-line. More news on: Agile Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

FDA Advisory Committee Meeting for Twirla® NDA Scheduled for October 30, 2019 Cash Expected to Enable Company to Fund Operations through end of First Quarter 2020 PRINCETON, N.J., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare c...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch to s...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Noteworthy events during the week of October 27 - November 2 for healthcare investors. More news on: AMAG Pharmaceuticals, Inc., Agile Therapeutics, Inc., Adamas Pharmaceuticals, Inc., Healthcare stocks news, , Read more ...

The following slide deck was published by Agile Therapeutics, Inc. in conjunction with this Read more ...

Back in May, Agile Therapeutics ( AGRX ), publicized that they resubmitted Twirla’s NDA to FDA. Twirla is Agile’s lead product candidate that is a low-dose combination hormonal contraceptive patch. Subsequently, Agile stated that the FDA accepted the NDA resubmission with t...